METHOD OF PYELONEPHRITIS DIAGNOSIS IN PATIENTS WITH NEPHROLITHIASIS

摘要

the invention u043eu0442u043du043eu0441u0438u0442u0441u00a0; in medicine - to urology, and u043au0430u0441u0430u0435u0442u0441u00a0 diagnosis u043fu0438u0435u043bu043eu043du0435u0444u0440u0438u0442u0430 in patients with u043du0435u0444u0440u043eu043bu0438u0442u0438u0430u0437u043eu043c. to improve the accuracy of diagnosis u0438u0437u043eu0431u0440u0435u0442u0435u043du0438u00a0 u00a0u0432u0438u043bu043eu0441u044c u043fu0438u0435u043bu043eu043du0435u0444u0440u0438u0442u0430 in the absence of u0431u0430u043au0442u0435u0440u0438u0443u0440u0438u0438 diagnostic u0442u0438u0442u0440u0435 (105 a / ml).u0434u043bu00a0 this u043eu043fu0440u0435u0434u0435u043bu00a0u044eu0442 immunological aspect factors of u0430u043du0442u0438u0438u043du0444u0435u043au0446u0438u043eu043du043du043eu0439 resistance: u0437u043du0430u0447u0435u043du0438u00a0 immunoglobulins m and g / igm, igg, u0433u0435u043cu043eu043bu0438u0442u0438u0447u0435u0441u043au043eu0433u043e u043au043eu043cu043fu043bu0435u043cu0435 u043du0442u0430 (CHso), u0444u0430u0433u043eu0446u0438u0442u0430u0440u043du043eu0439 activity u043du0435u0439u0442u0440u043eu0444u0438u043bu043eu0432 (fa) and in the presence of at least one of the indicators to the level of u0434u043bu00a0 igm, igg above 160 i / ml, CHso above 40 units., f above 25%, regardless of the u043du0430u043bu0438u0447u0438u00a0 u0431u0430u043au0442u0435u0440u0438u0443u0440u0438u0438 u0434u0438u0430u0433u043du043eu0441u0442u0438u0440u0443u044eu0442 pyelonephritis. the accuracy of the method increases from 30 to 51% to 91.5%.